0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Informed Consent for Tests for Prostate Cancer-Reply

Mark S. Litwin, MD, MPH
JAMA. 1995;274(2):128. doi:10.1001/jama.1995.03530020045024.
Text Size: A A A
Published online

In Reply.  —While Dr Marshall correctly points out the morbidity often associated with treatment for localized prostate cancer, he neglects a fundamental finding of our study: general healthrelated quality of life was not discernibly affected in these men, despite the pelvic dysfunctions they may have experienced.Informed decision making and shared responsibility are clearly the best ways for clinicians to guide patients through uncertain clinical choices. But Marshall's suggested informed consent for DRE and PSA testing would heavy-handedly push patients away from prostate evaluation. His detailed description of the risks, with mere lip service paid to the benefits, would be unfair to patients. As anyone who has lost a relative or friend to prostate cancer can attest, this disease can cause great disability, pain, and distress.1Our best defense against prostate cancer is probably early diagnosis. Despite a controversial literature, PSA has been proven highly accurate (91% specific and

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();